Schedule 13G ownership disclosure

Harmony Biosciences Holdings Inc

Common Stock, $0.00001 par value per share · CUSIP: 413197104

Event date: 2025-09-30

Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.

Filing-level shares
Unavailable
Percent of class
Unavailable
  • Valor IV Pharma Holdings, LLC

    Shares: 0.00 · Class: 0.0%

  • Valor Equity Partners IV L.P.

    Shares: 766,836.00 · Class: 1.3%

  • Valor Equity Partners IV-A L.P.

    Shares: 0.00 · Class: 0.0%

  • Valor Equity Partners IV-B L.P.

    Shares: 396,651.00 · Class: 0.7%

  • Valor Equity Associates IV L.P.

    Shares: 1,268,204.00 · Class: 2.2%

  • Valor Equity Capital IV LLC

    Shares: 1,268,204.00 · Class: 2.2%

  • Valor Management L.P.

    Shares: 1,297,701.00 · Class: 2.2%

  • Antonio J. Gracias

    Shares: 1,831,327.00 · Class: 3.2%

  • Juan A. Sabater

    Shares: 1,392,250.00 · Class: 2.4%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001213900-25-111024
Form type
SCHEDULE 13G/A
Filer
Harmony Biosciences Holdings, Inc.
CIK
CIK 1802665
Filed
Nov 14, 2025
Reporting period
Sep 30, 2025
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub